RPS7 promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer.

CONCLUSIONS: RPS7 is a newly verified tumor promoter in PCa, and promotes cell migration by targeting epithelial-to-mesenchymal transition pathway. Thus, inhibition of RPS7-epithelial to-mesenchymal transition signaling might represent a prospective approach toward limiting prostate tumor progression. PMID: 30737160 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30737160?dopt=Abstract

Source: Urologic Oncology - February 5, 2019 Category: Urology & Nephrology Authors: Wen Y, An Z, Qiao B, Zhang C, Zhang Z Tags: Urol Oncol Source Type: research